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ABSTRACT
  
TITLE: Time course of axial length changes in response to competing episodes of myopic and hyperopic defocus
ABSTRACT BODY: 
Purpose: To investigate the short-term changes in human axial length (AxL) in response to continuous and competing
episodes of myopic and hyperopic defocus.
Methods: The right eye of 16 young adults was exposed to 60 min episodes of either continuous or competing myopic
and hyperopic defocus (+3 D & -3 D), with the left eye optimally corrected to maintain far accommodation. During
competing defocus, the eye was exposed to either 30 min or 15 min of alternating cycles of myopic and hyperopic
defocus, with the order of lens wear reversed in separate sessions to assess the effects of defocus order. During each
60 min trial, the subjects watched a movie at 6 m in low photopic conditions. The right eye’s AxL was measured at
baseline and then at 15 min intervals using Lenstar optical biometry. A binocular beam splitter periscope system was
used to maintain distance fixation (left eye) and defocus exposure (right eye) during measurements.
Results: AxL underwent a greater magnitude of change during continuous defocus than during competing defocus.
The maximum AxL change observed during continuous hyperopic defocus was +7 ± 2 µm of elongation (p = 0.015)
and during continuous myopic defocus was -8 ± 2 µm of reduction in AxL (p = 0.07). When the eye was exposed to 30
min cycles of competing myopic and hyperopic defocus of equal duration, the opposing blur sessions cancelled each
other and the eye was at near baseline levels following the final defocus session (final change from baseline, both p >
0.05). When the frequency of alternating cycles was 15 min, there was a slight AxL reduction after 60 min of myopic
then hyperopic defocus, and hyperopic then myopic defocus, and were -3 ± 2 µm and -4 ± 2 µm, respectively (final
change from baseline, both p > 0.05) (Figure 1).
Conclusions: In the human eye, the AxL changes within minutes in response to short-term imposed myopic and
hyperopic defocus. With competing defocus, at 30 min exposure frequencies, the effects of myopic and hyperopic blur
largely cancel each other. At higher frequencies (15 min of alternating exposure), the effect on AxL of myopic defocus
appears to be slightly more potent than hyperopic defocus.
Fiqure 1. Plot of mean change in AxL from baseline during 60 min alternating cycles (15 min) of myopic then
hyperopic defocus, and hyperopic then myopic defocus in all subjects. Solid symbol indicates significant mean
difference from the baseline AxL.
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